Re: Bioton technologia

Na otarcie łez info sprzed trzech dni o zakończeniu z powodzeniem projektu GensuApp z MiyaHealth. Leszcz potrzebuje takich informacji jak ryba wody i grzyb deszczu. Ale co z tego jeśli chodzi o kurs?....... POŁÓDNIE!

BIOTON S.A.
7672 obserwujących
3 dni

Together with MiyaHealth, a Singapore-headquartered global SaaS HealthTech, we created GensuApp platform, a chronic disease management platform for people with diabetes. MiyaHealth has just announced that it has secured ISO 13845:2016 certification and a CE Mark for GensuApp. GensuApp is now officially recognized as a Class I medical device in Europe. “Today’s technology, if adapted and used correctly can greatly assist patients, carers and doctors in living a better quality of life and to avoid severe adverse effects of their conditions. Bioton S.A. decided to develop GensuApp with MiyaHealth to enable access to rapidly processed data and AI technology,” said Jeremy Launders, CEO at Bioton S.A. “This partnership supports the course of our patient’s treatment and management of their conditions, ultimately leading to better outcomes. Managing diabetes can be challenging due to the numerous tasks required to achieve optimal glycaemic control. We have customised GensuApp with MiyaHealth to provide a comprehensive overview, offering patients and doctors real-time data to empower them to make better immediate decisions. Being the first of its kind in Poland, the GensuApp will allow us to support a wider network of people with diabetes. During our pilot programs, we have received excellent feedback from our patients.”

https://www.linkedin.com/posts/bioton_bioton-pi%C4%99knie-roz%C5%9Bwietlony-nawet-w-nocy-activity-6795256111156006913-FrEU